177 related articles for article (PubMed ID: 12483152)
1. [Molecular pathways of pancreatic carcinogenesis].
Torrisani J; Buscail L
Ann Pathol; 2002 Oct; 22(5):349-55. PubMed ID: 12483152
[TBL] [Abstract][Full Text] [Related]
2. [New molecular targets in pancreatic cancer].
Torrisani J; Bournet B; Cordelier P; Buscail L
Bull Cancer; 2008 May; 95(5):503-12. PubMed ID: 18541514
[TBL] [Abstract][Full Text] [Related]
3. K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster.
Cerny WL; Mangold KA; Scarpelli DG
Cancer Res; 1992 Aug; 52(16):4507-13. PubMed ID: 1643642
[TBL] [Abstract][Full Text] [Related]
4. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
5. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
6. Molecular aspects of carcinogenesis in pancreatic cancer.
Koliopanos A; Avgerinos C; Paraskeva C; Touloumis Z; Kelgiorgi D; Dervenis C
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):345-56. PubMed ID: 18693168
[TBL] [Abstract][Full Text] [Related]
7. Molecular diagnosis of pancreatic cancer.
Inoue S; Tezel E; Nakao A
Hepatogastroenterology; 2001; 48(40):933-8. PubMed ID: 11490843
[TBL] [Abstract][Full Text] [Related]
8. Multiple genetic alterations in hamster pancreatic ductal adenocarcinomas.
Chang KW; Laconi S; Mangold KA; Hubchak S; Scarpelli DG
Cancer Res; 1995 Jun; 55(12):2560-8. PubMed ID: 7780969
[TBL] [Abstract][Full Text] [Related]
9. Ki-ras codon 12 point mutation and p53 mutation in pancreatic diseases.
Yamaguchi K; Chijiiwa K; Noshiro H; Torata N; Kinoshita M; Tanaka M
Hepatogastroenterology; 1999; 46(28):2575-81. PubMed ID: 10522044
[TBL] [Abstract][Full Text] [Related]
10. Genomic p53 mutation in a chemically induced hamster pancreatic ductal adenocarcinoma.
Chang KW; Mangold KA; Hubchak S; Laconi S; Scarpelli DG
Cancer Res; 1994 Jul; 54(14):3878-83. PubMed ID: 8033110
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of inducible nitric oxide synthase (iNOS) in N-nitrosobis(2-oxopropyl)amine-induced hamster pancreatic carcinogenesis and prevention of cancer development by ONO-1714, an iNOS inhibitor.
Takahashi M; Kitahashi T; Ishigamori R; Mutoh M; Komiya M; Sato H; Kamanaka Y; Naka M; Maruyama T; Sugimura T; Wakabayashi K
Carcinogenesis; 2008 Aug; 29(8):1608-13. PubMed ID: 18567618
[TBL] [Abstract][Full Text] [Related]
13. Exclusion of SMAD4 mutation as an early genetic change in human pancreatic ductal tumorigenesis.
Inoue H; Furukawa T; Sunamura M; Takeda K; Matsuno S; Horii A
Genes Chromosomes Cancer; 2001 Jul; 31(3):295-9. PubMed ID: 11391801
[TBL] [Abstract][Full Text] [Related]
14. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
[TBL] [Abstract][Full Text] [Related]
15. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden).
de vos tot Nederveen Cappel WH; Offerhaus GJ; van Puijenbroek M; Caspers E; Gruis NA; De Snoo FA; Lamers CB; Griffioen G; Bergman W; Vasen HF; Morreau H
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3598-605. PubMed ID: 14506146
[TBL] [Abstract][Full Text] [Related]
17. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas.
Mueller J; Gansauge S; Mattfeldt T
Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268
[TBL] [Abstract][Full Text] [Related]
18. Bile-reflux into the pancreatic ducts is associated with the development of intraductal papillary carcinoma in hamsters.
Adachi T; Tajima Y; Kuroki T; Mishima T; Kitasato A; Fukuda K; Tsutsumi R; Kanematsu T
J Surg Res; 2006 Nov; 136(1):106-11. PubMed ID: 16863651
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of the E-cadherin gene and its aberrant DNA methylation in hamster pancreatic tumors.
Shimizu K; Hanaoka M; Kato A; Fujii H; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2005 Oct; 336(1):49-53. PubMed ID: 16125139
[TBL] [Abstract][Full Text] [Related]
20. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice.
Brembeck FH; Schreiber FS; Deramaudt TB; Craig L; Rhoades B; Swain G; Grippo P; Stoffers DA; Silberg DG; Rustgi AK
Cancer Res; 2003 May; 63(9):2005-9. PubMed ID: 12727809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]